In the case of EA with PAX2 loss, the biological significance of PAX2 loss is substantiated by concurrent PTEN loss/aberrancy, providing further evidence that a subset of EA may be significant precursor lesions (ie, intraepithelial carcinomas). This evidence concerns the gene PAX2 and in situ carcinoma.